Symbol="ARWR"
AssetType="Common Stock"
Name="Arrowhead Pharmaceuticals Inc"
Description="Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California."
CIK="879407"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="3084065000"
EBITDA="-169208000"
PERatio="None"
PEGRatio="-1.32"
BookValue="3.406"
DividendPerShare="0"
DividendYield="0"
EPS="-1.44"
RevenuePerShareTTM="2.408"
ProfitMargin="-0.707"
OperatingMarginTTM="-0.705"
ReturnOnAssetsTTM="-0.146"
ReturnOnEquityTTM="-0.43"
RevenueTTM="256213000"
GrossProfitTTM="243231000"
DilutedEPSTTM="-1.44"
QuarterlyEarningsGrowthYOY="0.098"
QuarterlyRevenueGrowthYOY="-0.512"
AnalystTargetPrice="59.69"
TrailingPE="-"
ForwardPE="111.11"
PriceToSalesRatioTTM="14.71"
PriceToBookRatio="8.04"
EVToRevenue="11.97"
EVToEBITDA="-17.32"
Beta="0.957"
num_52WeekHigh="48.48"
num_52WeekLow="23.09"
num_50DayMovingAverage="34.4"
num_200DayMovingAverage="33.11"
SharesOutstanding="106900000"
DividendDate="None"
ExDividendDate="None"
symbol="ARWR"
open="28.79"
high="29.19"
low="28.56"
price="28.85"
volume="667895.00"
latest_trading_day="2023-08-11"
previous_close="28.97"
change="-0.12"
change_percent="-0.4142%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="979569"
Change_recent_avg="-0.07"
Delta_recent_avg="1.31"
Variance_recent_avg="0.65"
Change_ratio_recent_avg="-0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="502"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_negative_thumbnail_id_2="1100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="678"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
